| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4320998
[patent_doc_number] => 06331416
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells'
[patent_app_type] => 1
[patent_app_number] => 9/329234
[patent_app_country] => US
[patent_app_date] => 1999-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17386
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331416.pdf
[firstpage_image] =>[orig_patent_app_number] => 329234
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/329234 | Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells | Jun 9, 1999 | Issued |
Array
(
[id] => 733658
[patent_doc_number] => 07038106
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-02
[patent_title] => 'Detection of neural activity'
[patent_app_type] => utility
[patent_app_number] => 09/701996
[patent_app_country] => US
[patent_app_date] => 1999-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 9
[patent_no_of_words] => 5979
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/038/07038106.pdf
[firstpage_image] =>[orig_patent_app_number] => 09701996
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/701996 | Detection of neural activity | Jun 6, 1999 | Issued |
Array
(
[id] => 4160063
[patent_doc_number] => 06156888
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => 'Hybrid proteins with modified activity'
[patent_app_type] => 1
[patent_app_number] => 9/324934
[patent_app_country] => US
[patent_app_date] => 1999-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21227
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156888.pdf
[firstpage_image] =>[orig_patent_app_number] => 324934
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/324934 | Hybrid proteins with modified activity | Jun 2, 1999 | Issued |
| 09/322400 | METHODS OF ALTERING CARDIAC CELL PHENOTYPE | May 27, 1999 | Abandoned |
Array
(
[id] => 4419593
[patent_doc_number] => 06225119
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-01
[patent_title] => 'Production of megakaryocytes by the use of human mesenchymal stem cells'
[patent_app_type] => 1
[patent_app_number] => 9/316797
[patent_app_country] => US
[patent_app_date] => 1999-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 21
[patent_no_of_words] => 7008
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/225/06225119.pdf
[firstpage_image] =>[orig_patent_app_number] => 316797
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/316797 | Production of megakaryocytes by the use of human mesenchymal stem cells | May 20, 1999 | Issued |
Array
(
[id] => 6016912
[patent_doc_number] => 20020103145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'IMMUNIZATION OF INFANTS'
[patent_app_type] => new
[patent_app_number] => 09/308511
[patent_app_country] => US
[patent_app_date] => 1999-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 13951
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103145.pdf
[firstpage_image] =>[orig_patent_app_number] => 09308511
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/308511 | IMMUNIZATION OF INFANTS | May 18, 1999 | Abandoned |
Array
(
[id] => 6654034
[patent_doc_number] => 20030077249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'CELL ACTIVATION PROCESS AND REAGENTS THEREFOR'
[patent_app_type] => new
[patent_app_number] => 09/091608
[patent_app_country] => US
[patent_app_date] => 1999-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 13282
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077249.pdf
[firstpage_image] =>[orig_patent_app_number] => 09091608
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/091608 | CELL ACTIVATION PROCESS AND REAGENTS THEREFOR | May 16, 1999 | Abandoned |
| 09/311720 | Genetic immunization by epicutaneous application | May 13, 1999 | Abandoned |
Array
(
[id] => 1189572
[patent_doc_number] => 06734338
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-11
[patent_title] => 'Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies'
[patent_app_type] => B1
[patent_app_number] => 09/311599
[patent_app_country] => US
[patent_app_date] => 1999-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 13172
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/734/06734338.pdf
[firstpage_image] =>[orig_patent_app_number] => 09311599
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/311599 | Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies | May 12, 1999 | Issued |
Array
(
[id] => 1475618
[patent_doc_number] => 06388062
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Modified p53 tetramerization domains having hydrophobic amino acid substitutions'
[patent_app_type] => B1
[patent_app_number] => 09/305914
[patent_app_country] => US
[patent_app_date] => 1999-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6970
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/388/06388062.pdf
[firstpage_image] =>[orig_patent_app_number] => 09305914
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/305914 | Modified p53 tetramerization domains having hydrophobic amino acid substitutions | May 4, 1999 | Issued |
Array
(
[id] => 6535642
[patent_doc_number] => 20020026651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'PATHOGENIC TAU MUTATIONS'
[patent_app_type] => new
[patent_app_number] => 09/302964
[patent_app_country] => US
[patent_app_date] => 1999-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7738
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20020026651.pdf
[firstpage_image] =>[orig_patent_app_number] => 09302964
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/302964 | Pathogenic tau mutations | Apr 29, 1999 | Issued |
Array
(
[id] => 6603730
[patent_doc_number] => 20020015709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'ADMINISTRATION OF LEPTIN'
[patent_app_type] => new
[patent_app_number] => 09/302117
[patent_app_country] => US
[patent_app_date] => 1999-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6297
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20020015709.pdf
[firstpage_image] =>[orig_patent_app_number] => 09302117
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/302117 | Administration of leptin | Apr 28, 1999 | Issued |
| 09/301305 | HIGHLY CONSERVED POLYNUCLEOTIDE SEQUENCE LINKED TO A GENETIC PREDISPOSITION TO SCHIZOPHRENIA, A METHOD OF DIAGNOSIS, AND APPLICATIONS THEREOF | Apr 28, 1999 | Abandoned |
| 09/298508 | SOMATIC CELL LINE | Apr 21, 1999 | Abandoned |
Array
(
[id] => 1143106
[patent_doc_number] => 06777546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-17
[patent_title] => 'Methods and substances for preventing and treating autoimmune disease'
[patent_app_type] => B2
[patent_app_number] => 09/296981
[patent_app_country] => US
[patent_app_date] => 1999-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 23898
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/777/06777546.pdf
[firstpage_image] =>[orig_patent_app_number] => 09296981
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/296981 | Methods and substances for preventing and treating autoimmune disease | Apr 21, 1999 | Issued |
Array
(
[id] => 1071953
[patent_doc_number] => 06841537
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-11
[patent_title] => 'Combination therapy using nucleic acids and conventional drugs'
[patent_app_type] => utility
[patent_app_number] => 09/295663
[patent_app_country] => US
[patent_app_date] => 1999-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 21853
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/841/06841537.pdf
[firstpage_image] =>[orig_patent_app_number] => 09295663
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/295663 | Combination therapy using nucleic acids and conventional drugs | Apr 20, 1999 | Issued |
| 09/295849 | NEUROPEPTIDES AND THEIR USE FOR PEST CONTROL | Apr 20, 1999 | Abandoned |
Array
(
[id] => 1370132
[patent_doc_number] => 06562590
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-13
[patent_title] => 'Transformed cells useful for the control of pests'
[patent_app_type] => B1
[patent_app_number] => 09/295846
[patent_app_country] => US
[patent_app_date] => 1999-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 13554
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562590.pdf
[firstpage_image] =>[orig_patent_app_number] => 09295846
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/295846 | Transformed cells useful for the control of pests | Apr 20, 1999 | Issued |
Array
(
[id] => 1071954
[patent_doc_number] => 06841538
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-11
[patent_title] => 'Combination therapy using nucleic acids and radio therapy'
[patent_app_type] => utility
[patent_app_number] => 09/295925
[patent_app_country] => US
[patent_app_date] => 1999-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 21545
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/841/06841538.pdf
[firstpage_image] =>[orig_patent_app_number] => 09295925
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/295925 | Combination therapy using nucleic acids and radio therapy | Apr 20, 1999 | Issued |
| 09/292723 | TRANSFECTION, STORAGE AND TRANSFER OF MALE GERM CELLS FOR GENERATION OF SELECTABLE TRANSGENIC STEM CELLS | Apr 14, 1999 | Abandoned |